DocGo (NASDAQ:DCGO – Get Free Report) had its price target lowered by stock analysts at Needham & Company LLC from $7.00 to $4.00 in a research note issued to investors on Friday,Benzinga reports. The firm currently has a “buy” rating on the stock. Needham & Company LLC’s target price points to a potential upside of 2.04% from the company’s previous close.
DocGo Trading Down 3.4 %
DocGo stock opened at $3.92 on Friday. DocGo has a 1-year low of $2.75 and a 1-year high of $5.68. The firm has a market capitalization of $400.04 million, a PE ratio of 14.00, a price-to-earnings-growth ratio of 14.16 and a beta of 1.00. The firm’s 50 day simple moving average is $4.62 and its 200 day simple moving average is $4.02.
Insider Buying and Selling
In other DocGo news, General Counsel Ely D. Tendler sold 23,088 shares of the company’s stock in a transaction dated Monday, December 16th. The stock was sold at an average price of $4.44, for a total value of $102,510.72. Following the transaction, the general counsel now directly owns 175,645 shares in the company, valued at $779,863.80. This represents a 11.62 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 2.70% of the stock is currently owned by company insiders.
Institutional Trading of DocGo
DocGo Company Profile
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Recommended Stories
- Five stocks we like better than DocGo
- The 3 Best Retail Stocks to Shop for in August
- Why Smart Investors Are Watching These 3 Undervalued Stocks
- Insider Trading – What You Need to Know
- 3 Stocks Breaking Out with More Growth Potential Ahead
- Insider Trades May Not Tell You What You Think
- Not Just China: 3 European Stocks Gaining Investor Interest
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.